These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1971163)

  • 1. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat.
    Furst SR; Weinger MB
    Anesthesiology; 1990 May; 72(5):882-8. PubMed ID: 1971163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
    Weinger MB; Segal IS; Maze M
    Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine.
    Zornow MH
    Neuropharmacology; 1991 Oct; 30(10):1065-71. PubMed ID: 1684646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive properties of intrathecal dexmedetomidine in rats.
    Fisher B; Zornow MH; Yaksh TL; Peterson BM
    Eur J Pharmacol; 1991 Jan; 192(2):221-5. PubMed ID: 1674472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.
    Zornow MH; Fleischer JE; Scheller MS; Nakakimura K; Drummond JC
    Anesth Analg; 1990 Jun; 70(6):624-30. PubMed ID: 1971500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
    Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor.
    Segal IS; Vickery RG; Walton JK; Doze VA; Maze M
    Anesthesiology; 1988 Dec; 69(6):818-23. PubMed ID: 2848424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal and systemic action of the alpha 2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response.
    Sabbe MB; Penning JP; Ozaki GT; Yaksh TL
    Anesthesiology; 1994 May; 80(5):1057-72. PubMed ID: 7912480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.
    Kamibayashi T; Mammoto T; Hayashi Y; Yamatodani A; Takada K; Sasaki S; Yoshiya I
    Anesthesiology; 1995 Nov; 83(5):1082-9. PubMed ID: 7486159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.
    Doze VA; Chen BX; Maze M
    Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular actions of medetomidine and their reversal by atipamezole.
    Savola JM
    Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.
    Hoffman WE; Kochs E; Werner C; Thomas C; Albrecht RF
    Anesthesiology; 1991 Aug; 75(2):328-32. PubMed ID: 1677549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
    Potter DE; Ogidigben MJ
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs.
    Nguyen D; Abdul-Rasool I; Ward D; Hsieh J; Kobayashi D; Hadlock S; Singer F; Bloor B
    Anesthesiology; 1992 Apr; 76(4):573-9. PubMed ID: 1347980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
    Correa-Sales C; Rabin BC; Maze M
    Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat.
    Weinger MB; Chen DY; Lin T; Lau C; Koob GF; Smith NT
    Brain Res; 1995 Jan; 669(1):10-8. PubMed ID: 7712151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serotonin metabolism in the rat raphe magnus and cardiovascular modifications following systemic administration of clonidine and other central alpha 2-agonists: an in vivo voltammetry study.
    Aslanian V; Renaud B
    Neuropharmacology; 1989 Apr; 28(4):387-95. PubMed ID: 2568594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.